search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
MEDICAL | MATERIALS


Increasing need for medical


plastics during Covid-19 The global Covid-19 pandemic has certainly had a major impact on the injection moulding industry, but the growth of medical materials continues in many directions. Mark Holmes reports


The past year, dominated by Covid-19, has been exceptional for plastic mouldings linked to diag- nostic instruments and consumables, as well as ventilators, reports MedPharmPlast Europe (MPPE) – a sector group of processor organisation EuPC, created in 2014 for companies involved in the entire supply chain of plastic medical devices and pharmaceutical packaging in Europe. How- ever, this has been balanced by reduced demand for plastics related to surgical interventions. Nevertheless, the global market for injection moulded plastics for medical applications remains robust and continues to grow consistently at between 5-7%, with North America and Europe being the largest markets, but consumption in China and India growing rapidly. “China has a high concentration of Western injection moulding companies, but many have faced


www.injectionworld.com


some challenges in capturing projects from Chinese OEMs,” says Steve Duckworth, MPPE President. “Given the size of the population and governmental strategy, China’s domestic medical device producers have strong domestic demand. However, they also have global ambitions, targeting developing markets such as Brazil and Africa. For many years India has been a hub for manufacturing pharmaceu- ticals and pharmaceutical intermediates through companies such as Sun Pharma, Dr Reddy’s, Cipla and Glenmark. However, for medical and drug- delivery devices India has lacked some infrastructure in design and development. Over the past few years, the Indian government has encouraged a Made in India strategy. With strong core engineer- ing skills, India has been developing a stronger home-grown capability, which also covers design and development. This is now playing an important


Main image: Nextis is mould- ing several parts for an advanced respirator from Air Liquide Medical Systems, including a flexible protective cover for the device’s USP port made using a Kraiburg TPE material


January/February 2021 | INJECTION WORLD 13


IMAGE: ALMS


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48